Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid

J Antimicrob Chemother. 2015 Apr;70(4):1259-61. doi: 10.1093/jac/dku486. Epub 2014 Nov 27.

Authors

Steven J Nigro¹, Kathryn E Holt², Derek Pickard³, Ruth M Hall⁴

Affiliations

¹ School of Molecular Bioscience, The University of Sydney, Sydney, New South Wales, Australia steven.nigro@sydney.edu.au.
² Department of Biochemistry and Molecular Biology and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia.
³ Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
⁴ School of Molecular Bioscience, The University of Sydney, Sydney, New South Wales, Australia.

No abstract available

Keywords: A. baumannii; aphA6; blaOXA-23; resistance plasmids.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acinetobacter Infections / microbiology
Acinetobacter baumannii / drug effects*
Acinetobacter baumannii / genetics*
Acinetobacter baumannii / isolation & purification
Amikacin / pharmacology*
Anti-Bacterial Agents / pharmacology*
Australia
Carbapenems / pharmacology*
Conjugation, Genetic
DNA Transposable Elements
DNA, Bacterial / chemistry
DNA, Bacterial / genetics
Drug Resistance, Bacterial*
Gene Order
Gene Transfer, Horizontal
Genes, Bacterial
Humans
Molecular Sequence Data
Plasmids*
Sequence Analysis, DNA

Substances

Anti-Bacterial Agents
Carbapenems
DNA Transposable Elements
DNA, Bacterial
Amikacin

Associated data

GENBANK/KM977710

Grants and funding

628930/Wellcome Trust/United Kingdom